Zhou Peilin, Wang Wenqiang, Liu Yongzhen, Chen Xiang, Mo Yongjun, Su Hongjie, Nie Xinyu, Hua Qikai
{"title":"Inflammatory cytokines, metabolites, and rheumatoid arthritis.","authors":"Zhou Peilin, Wang Wenqiang, Liu Yongzhen, Chen Xiang, Mo Yongjun, Su Hongjie, Nie Xinyu, Hua Qikai","doi":"10.1093/postmj/qgae146","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by persistent inflammation and joint destruction. Although the roles of inflammatory cytokines and metabolites in RA pathogenesis have caught a lot of attention, there is a lack of systematic studies, and their causal relationships remain unclear.</p><p><strong>Methods: </strong>We conducted a two-step mendelian randomization analysis utilizing genetic data from genome-wide association studies (GWAS) of inflammatory cytokines, metabolites, and RA. The first step assessed the causal effect of 91 inflammatory cytokines and 1400 metabolites on RA risk using inverse variance weighted method, complemented by MR-Egger, weighted median, simple mode and MR-PRESSO to ensure robustness and assess pleiotropy. The second step evaluated the mediation effects of selected metabolites on the relationship between cytokines and RA.</p><p><strong>Results: </strong>The analysis identified 9 inflammatory cytokines, including IL-1α and IL-10, which significantly increase RA risk, while TNF-β exhibited a protective effect. Additionally, 6 metabolites were associated with increased RA risk, including 1-(1-enyl-palmitoyl)-2-arachidonoyl-GPE and arachidonate (20:4n6). Conversely, 5 metabolites, such as docosatrienoate (22:3n3) and Cholesterol, were found to reduce RA risk. The mediation analysis revealed that TNF-β may exerts its protective effect through its influence on specific metabolites, and X-24949, which accounted for a -2.58% mediated effect in the TNF-β-RA causal pathway.</p><p><strong>Conclusion: </strong>This study explores the complex interplay between inflammatory cytokines, metabolites, and RA. The findings suggest potential biomarkers for early diagnosis and novel therapeutic targets, particularly those related to lipid metabolites and specific cytokines like TNF-β. Key message What is already known on this topic Inflammatory factors and metabolites are considered to be related to the onset and progression of RA. What this study adds We conducted a MR analysis to identify all inflammatory factors and metabolites associated with RA and calculated the mediation effect of inflammatory cytokines on RA through metabolites. This study contributes to a comprehensive understanding of the pathophysiological processes of RA. How this study might affect research, practice or policy This has laid the groundwork for developing early diagnosis methods and future treatments.</p>","PeriodicalId":20374,"journal":{"name":"Postgraduate Medical Journal","volume":" ","pages":""},"PeriodicalIF":3.6000,"publicationDate":"2024-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Postgraduate Medical Journal","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/postmj/qgae146","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by persistent inflammation and joint destruction. Although the roles of inflammatory cytokines and metabolites in RA pathogenesis have caught a lot of attention, there is a lack of systematic studies, and their causal relationships remain unclear.
Methods: We conducted a two-step mendelian randomization analysis utilizing genetic data from genome-wide association studies (GWAS) of inflammatory cytokines, metabolites, and RA. The first step assessed the causal effect of 91 inflammatory cytokines and 1400 metabolites on RA risk using inverse variance weighted method, complemented by MR-Egger, weighted median, simple mode and MR-PRESSO to ensure robustness and assess pleiotropy. The second step evaluated the mediation effects of selected metabolites on the relationship between cytokines and RA.
Results: The analysis identified 9 inflammatory cytokines, including IL-1α and IL-10, which significantly increase RA risk, while TNF-β exhibited a protective effect. Additionally, 6 metabolites were associated with increased RA risk, including 1-(1-enyl-palmitoyl)-2-arachidonoyl-GPE and arachidonate (20:4n6). Conversely, 5 metabolites, such as docosatrienoate (22:3n3) and Cholesterol, were found to reduce RA risk. The mediation analysis revealed that TNF-β may exerts its protective effect through its influence on specific metabolites, and X-24949, which accounted for a -2.58% mediated effect in the TNF-β-RA causal pathway.
Conclusion: This study explores the complex interplay between inflammatory cytokines, metabolites, and RA. The findings suggest potential biomarkers for early diagnosis and novel therapeutic targets, particularly those related to lipid metabolites and specific cytokines like TNF-β. Key message What is already known on this topic Inflammatory factors and metabolites are considered to be related to the onset and progression of RA. What this study adds We conducted a MR analysis to identify all inflammatory factors and metabolites associated with RA and calculated the mediation effect of inflammatory cytokines on RA through metabolites. This study contributes to a comprehensive understanding of the pathophysiological processes of RA. How this study might affect research, practice or policy This has laid the groundwork for developing early diagnosis methods and future treatments.
背景:类风湿性关节炎(RA)是一种慢性自身免疫性疾病,以持续性炎症和关节破坏为特征。尽管炎性细胞因子和代谢物在 RA 发病机制中的作用已引起广泛关注,但目前缺乏系统的研究,它们之间的因果关系仍不清楚:我们利用炎性细胞因子、代谢物和 RA 的全基因组关联研究(GWAS)的遗传数据进行了两步亡德尔随机分析。第一步采用反方差加权法评估了91种炎症细胞因子和1400种代谢物对RA风险的因果效应,并辅以MR-Egger、加权中位数、简单模式和MR-PRESSO以确保稳健性和评估多向性。第二步是评估选定代谢物对细胞因子与 RA 之间关系的中介效应:结果:分析发现,包括IL-1α和IL-10在内的9种炎症细胞因子会显著增加RA风险,而TNF-β则具有保护作用。此外,6 种代谢物与 RA 风险增加有关,包括 1-(1-烯基-棕榈酰基)-2-花生四烯酸-GPE 和花生四烯酸(20:4n6)。相反,5种代谢物,如二十二碳三烯酸酯(22:3n3)和胆固醇则可降低RA风险。中介分析显示,TNF-β可能通过影响特定代谢物和X-24949来发挥其保护作用,X-24949在TNF-β-RA因果途径中的中介效应为-2.58%:本研究探讨了炎性细胞因子、代谢物和 RA 之间复杂的相互作用。研究结果提出了用于早期诊断的潜在生物标记物和新的治疗靶点,尤其是与脂质代谢物和特定细胞因子(如 TNF-β)相关的靶点。本主题的已知信息 炎症因子和代谢物被认为与RA的发病和进展有关。本研究的补充 我们进行了磁共振分析,以确定与 RA 相关的所有炎症因子和代谢物,并计算了炎症细胞因子通过代谢物对 RA 的中介效应。这项研究有助于全面了解 RA 的病理生理过程。本研究可能对研究、实践或政策产生的影响 本研究为开发早期诊断方法和未来治疗奠定了基础。
期刊介绍:
Postgraduate Medical Journal is a peer reviewed journal published on behalf of the Fellowship of Postgraduate Medicine. The journal aims to support junior doctors and their teachers and contribute to the continuing professional development of all doctors by publishing papers on a wide range of topics relevant to the practicing clinician and teacher. Papers published in PMJ include those that focus on core competencies; that describe current practice and new developments in all branches of medicine; that describe relevance and impact of translational research on clinical practice; that provide background relevant to examinations; and papers on medical education and medical education research. PMJ supports CPD by providing the opportunity for doctors to publish many types of articles including original clinical research; reviews; quality improvement reports; editorials, and correspondence on clinical matters.